Funded Tech Companies
Deka Biosciences
Headquartered in Germantown, Deka Biosciences has funding from Leaps by Bayer, Alexandria Venture Investments and Echo Investment Capital.
Company Overview
Company Name
Deka Biosciences
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
20271 Goldenrod Ln
Germantown, MD 20876
USA
Germantown, MD 20876
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
The Diakine� platform is a next-generation cytokine therapy created to treat cancer and inflammatory diseases based on each patient's individual immune response. Our platform harnesses the potential of the immune system by empowering it to safely combat inflammatory disease and cancer. It is the first therapy to combine two anti-inflammatory cytokines for inflammatory disease, or to combine an immune stimulating cytokine and an anti-inflammatory cytokine into a single treatment for cancer. Through targeting, these powerful cytokine combinations enrich in the affected tissue with the potential to drive disease control.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/28/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Mumm
Chief Medical Officer
Charlotte Moser
Company Investors
- Leaps by Bayer
- Alexandria Venture Investments
- Echo Investment Capital
- ATEM Capital
- Viva BioInnovator
- Plains Venture Partners
- MPM Capital (Detlev Biniszkiewicz)
- Amana Investments
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs